|
TFRC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.427800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.300400E-01 |
| Normal-vs-Stage2 |
9.502800E-01 |
| Normal-vs-Stage3 |
5.659200E-01 |
| Normal-vs-Stage4 |
3.928800E-01 |
| Stage1-vs-Stage2 |
6.210400E-01 |
| Stage1-vs-Stage3 |
9.506600E-01 |
| Stage1-vs-Stage4 |
1.930580E-01 |
| Stage2-vs-Stage3 |
6.514400E-01 |
| Stage2-vs-Stage4 |
5.510800E-01 |
| Stage3-vs-Stage4 |
2.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.198000E-01 |
| Normal-vs-AfricanAmerican |
5.668800E-01 |
| Normal-vs-Asian |
7.634400E-01 |
| Caucasian-vs-AfricanAmerican |
3.062400E-01 |
| Caucasian-vs-Asian |
6.947000E-01 |
| AfricanAmerican-vs-Asian |
8.510400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.087750E-01 |
| Normal-vs-Female |
7.729800E-02 |
| Male-vs-Female |
5.019000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.539800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.845200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.686800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.787000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.508600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.675400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.392600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.737200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.806600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.995200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.505600E-01 |
| Normal-vs-Grade 2 |
8.771800E-01 |
| Normal-vs-Grade 3 |
2.609600E-01 |
| Normal-vs-Grade 4 |
8.938000E-01 |
| Grade 1-vs-Grade 2 |
5.750200E-01 |
| Grade 1-vs-Grade 3 |
2.488800E-01 |
| Grade 1-vs-Grade 4 |
5.219000E-01 |
| Grade 2-vs-Grade 3 |
1.725760E-01 |
| Grade 2-vs-Grade 4 |
8.219400E-01 |
| Grade 3-vs-Grade 4 |
5.849600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.379400E-01 |
| Normal-vs-ccB subtype |
6.217000E-01 |
| ccA subtype-vs-ccB subtype |
7.378000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.203200E-01 |
| Normal-vs-N1 |
2.588600E-01 |
| N0-vs-N1 |
2.493800E-01 |
|
|
